The book "Molecular Targeted Therapy of Lung Cancer" offers a comprehensive analysis of the latest developments in molecular targeted therapy for lung cancer. It addresses the initial effectiveness of these therapies as well as the challenges posed by disease recurrence and the multitude of resistance mechanisms. The authors, leading experts in their field, discuss innovative approaches to overcoming these challenges and emphasize the need for new diagnostic technologies. Additionally, strategies for managing side effects and methods for assessing the efficacy and safety of these therapies are presented. This specialized book is aimed at students, postdoctoral researchers, educators, and scientists engaged in clinical and translational research on lung cancer, fostering new ideas for future advancements in this area.